This apparent contradiction may reflect the pleiotropic nature of GDF15, which not only marks local tumor behavior but may also indicate systemic effects, such as inflammation, cachexia, or immune modulation, that contribute to poorer outcomes independently of tumor stage. The gene discussed is GDF15; the disease is neoplasm.